Therapeutic Goods Administration approves Australian-made AstraZeneca coronavirus vaccine for use

More than 800,000 Australian-made doses of the AstraZeneca coronavirus vaccine have been approved for use by the national medical regulator.

On Sunday, the Therapeutic Goods Administration signed off on domestic manufacture of the vaccine, but was still undertaking so-called “batch testing.”

That’s when each batch of the vaccine is reviewed to check it has been made to the required standards. 

The doses have now been cleared, in what the TGA described as a “major step in Australia’s response to the COVID-19 pandemic”. 

The federal government says 50 million doses of the AstraZeneca vaccine will be manufactured in Australia by CSL. 

More to come.